But 47. 8 percent of the drugs relied at least indirectly on some federally funded research. The figures were higher for more medically important drugs: 17. 4 percent had a direct   patent, while 64. 5 percent had at least an indirect   influence. These figures are up sharply from before the 1980s. Such partnerships and licensing deals were encouraged by the 1980   and   Acts, and the 1986 Federal Technology Transfer Act. 